(PRWEB) September 12, 2012
Approved only for use in the lumber spine by The Food and Drug Administration in 2002, the Medtronic Infuse Bone Graft has been the center of numerous lawsuits and federal government inquiries after it was discovered that Medtronic was promoting the "off-label" and unapproved use of its own product.
The infoGraphic, webpage constructions, and examinations undertaken by the staff at d'Oliveira & Associates detail, not only the adverse side-effects and how much Medtronic profited from these promoted "off-labels" uses, but also gives a in-depth timeline showing the bone graft lawsuits and investigations.
The graphic goes from displaying the original approved and unapproved uses of the Infuse Bone Graft, to the investigations by the Department of Justice and the Senate Finance Committee, to employee whistle-blower lawsuits, and to reports detailing how the doctors conducting the Infuse Bone Graft clinical trial were paid by Medtronic to not disclose any adverse side effects. The detailed compilations shows that the off-label uses of the Medtronic Infuse Bone Graft have been linked to nerve injuries, uncontrollable bone growth, cancer, sterility.
If you or a loved one has undergone an off-label bone graft procedure involving the Medtronic Infuse Bone Graft, the attorneys at d'Oliveira & Associates urge you to contact them. Working with the leading lawyers handling medical device claims, d'Oliveira & Associates want you to know that you may be entitled to compensation. Please contact the law offices of d'Oliveira & Associates, P.C. at 1-800-992-6878 or fill out a contact form for a free legal consultation.